These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 18360931)
21. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: scleroderma. Krieg T; Hunzelmann N; Gabrielli A; Jablonska S Eur J Dermatol; 2008; 18(2):213-4. PubMed ID: 18424402 [No Abstract] [Full Text] [Related]
22. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: HIV infection. Ranki A Eur J Dermatol; 2008; 18(2):217-9. PubMed ID: 18424405 [No Abstract] [Full Text] [Related]
23. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: Epidermolysis bullosa. Bruckner-Tuderman L Eur J Dermatol; 2008; 18(2):214-6. PubMed ID: 18424403 [No Abstract] [Full Text] [Related]
24. Should children with a history of anaphylaxis to foods undergo challenge testing? Vlieg-Boerstra BJ; Duiverman EJ; van der Heide S; Bijleveld CM; Kukler J; Dubois AE Clin Exp Allergy; 2008 Dec; 38(12):1935-42. PubMed ID: 18771485 [TBL] [Abstract][Full Text] [Related]
26. Anaphylaxis: an overwhelming allergic reaction. Swift action is needed to short-circuit potentially deadly symptoms. Harv Womens Health Watch; 2009 Sep; 17(1):4-6. PubMed ID: 19928629 [No Abstract] [Full Text] [Related]
27. New action plans for the management of anaphylaxis. Kemp AS; Hu W Aust Fam Physician; 2009; 38(1-2):31-5. PubMed ID: 19283233 [TBL] [Abstract][Full Text] [Related]
28. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome. Fritsch P Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404 [No Abstract] [Full Text] [Related]
29. [Long-term management of patients experienced anaphylaxis]. Nagata M; Nakagome K; Sato N; Komiyama K Arerugi; 2009 Oct; 58(10):1395-400. PubMed ID: 19901508 [No Abstract] [Full Text] [Related]
30. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2008. Sicherer SH; Leung DY J Allergy Clin Immunol; 2009 Feb; 123(2):319-27. PubMed ID: 19203656 [TBL] [Abstract][Full Text] [Related]
31. Skin testing performed in individuals cannot be compared with responses from anaphylactic patients. Dewachter P; Mouton-Faivre C Anesth Analg; 2008 Oct; 107(4):1441; author reply 1441. PubMed ID: 18806067 [No Abstract] [Full Text] [Related]
32. Pediatricians' knowledge about recent advances in anaphylaxis treatment in Istanbul, Turkey. Cetinkaya F; Zübarioğlu AU; Göktaş S Turk J Pediatr; 2009; 51(1):19-21. PubMed ID: 19378886 [TBL] [Abstract][Full Text] [Related]
33. [From wheezing to anaphylactic shock: allergology for your practice]. Einecke U MMW Fortschr Med; 2008 Mar; 150(13):12-4, 16. PubMed ID: 18522349 [No Abstract] [Full Text] [Related]
34. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: chronic venous insufficiency. Ramelet AA Eur J Dermatol; 2008; 18(2):211-3. PubMed ID: 18424401 [No Abstract] [Full Text] [Related]
38. Anaphylaxis-Junior doctors' knowledge of guidelines. José RJ Resuscitation; 2009 Sep; 80(9):1091. PubMed ID: 19604617 [No Abstract] [Full Text] [Related]
39. Anaphylaxis-Junior doctors' knowledge of guidelines. Gopalakrishnan S; Alexander R Resuscitation; 2009 Mar; 80(3):383-4. PubMed ID: 19118935 [No Abstract] [Full Text] [Related]
40. Skin disease: a neglected public health problem. Khatami A; San Sebastian M Dermatol Clin; 2009 Apr; 27(2):99-101, v. PubMed ID: 19254651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]